Stock Track | IQVIA Shares Soar 5.23% as Argus Research Boosts Price Target

Stock Track

Jul 24, 2025

IQVIA Holdings Inc. (IQV) stock is experiencing a significant upturn in Thursday's pre-market trading, soaring 5.23% following a bullish analyst update. The surge comes as Argus Research raised its price target for IQVIA to $230 from $180, signaling strong confidence in the company's future performance.

The substantial increase in the price target, representing a 27.8% boost, has evidently caught the attention of investors. Argus Research's more optimistic outlook on IQVIA suggests that the firm sees potential for considerable growth and value creation in the coming months.

IQVIA, a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, has been gaining traction in the market. The raised price target could be attributed to the company's strong positioning in the healthcare information and technology sector, as well as potential growth opportunities in clinical trials and real-world evidence solutions.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1100793785"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1100793785\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1100793785?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-07-24 21:40","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1100793785","market":"hk","top_or_hot":-1,"title":"Stock Track | IQVIA Shares Soar 5.23% as Argus Research Boosts Price Target","media":"Stock Track","content":"<p>IQVIA Holdings Inc. (IQV) stock is experiencing a significant upturn in Thursday's pre-market trading, soaring 5.23% following a bullish analyst update. The surge comes as Argus Research raised its price target for IQVIA to $230 from $180, signaling strong confidence in the company's future performance.</p>\n\n<p>The substantial increase in the price target, representing a 27.8% boost, has evidently caught the attention of investors. Argus Research's more optimistic outlook on IQVIA suggests that the firm sees potential for considerable growth and value creation in the coming months.</p>\n\n<p>IQVIA, a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, has been gaining traction in the market. The raised price target could be attributed to the company's strong positioning in the healthcare information and technology sector, as well as potential growth opportunities in clinical trials and real-world evidence solutions.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | IQVIA Shares Soar 5.23% as Argus Research Boosts Price Target</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | IQVIA Shares Soar 5.23% as Argus Research Boosts Price Target\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-07-24 21:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>IQVIA Holdings Inc. (IQV) stock is experiencing a significant upturn in Thursday's pre-market trading, soaring 5.23% following a bullish analyst update. The surge comes as Argus Research raised its price target for IQVIA to $230 from $180, signaling strong confidence in the company's future performance.</p>\n\n<p>The substantial increase in the price target, representing a 27.8% boost, has evidently caught the attention of investors. Argus Research's more optimistic outlook on IQVIA suggests that the firm sees potential for considerable growth and value creation in the coming months.</p>\n\n<p>IQVIA, a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, has been gaining traction in the market. The raised price target could be attributed to the company's strong positioning in the healthcare information and technology sector, as well as potential growth opportunities in clinical trials and real-world evidence solutions.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"IQV","symbol_name":"艾昆纬","start_time":0,"source_url":"","article_id":"1100793785","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1100793785","pubTimestamp":1753364411,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"IQVIA Holdings Inc. (IQV) stock is experiencing a significant upturn in Thursday's pre-market trading, soaring 5.23% following a bullish analyst update. The surge comes as Argus Research raised its...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"IQV":"艾昆纬"},"translate_title":"股票追踪|Argus Research上调目标价，IQVIA股价飙升5.23%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"IQV":1},"content_text":"IQVIA Holdings Inc. (IQV) stock is experiencing a significant upturn in Thursday's pre-market trading, soaring 5.23% following a bullish analyst update. The surge comes as Argus Research raised its price target for IQVIA to $230 from $180, signaling strong confidence in the company's future performance.\nThe substantial increase in the price target, representing a 27.8% boost, has evidently caught the attention of investors. Argus Research's more optimistic outlook on IQVIA suggests that the firm sees potential for considerable growth and value creation in the coming months.\nIQVIA, a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry, has been gaining traction in the market. The raised price target could be attributed to the company's strong positioning in the healthcare information and technology sector, as well as potential growth opportunities in clinical trials and real-world evidence solutions.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}